EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity

Lea Prengemann, Robert Stein iD, Ruth Gausche iD, Christoph Beger iD, Mandy Vogel iD, Eric Wenzel, Anette Stoltze, Wieland Kiess iD, Roland Pfäffle, Antje Körner iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Lea Prengemann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pediatric Research, Medical Faculty, University of Leipzig, University Hospital for Children & Adolescents, 04103 Leipzig, Germany. Hauptthemen laut MEDLINE: Infant, Small for Gestational Age, Human Growth Hormone, Insulin Resistance, Insulin. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation, Federal Ministry of Research, Technology and Space, German Center for Child and Adolescent Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Being born small for gestational age (SGA) and growth hormone (GH) treatment are linked to disturbed glucose-insulin metabolism.

Objective

We investigated how GH treatment affects glucose-insulin metabolism in children born SGA compared to children with isolated growth hormone deficiency (iGHD), obesity and lean controls.

Methods

We analyzed glucose-insulin metabolism indices derived from oral glucose tolerance tests (Matsuda index, AUC insulin) and fasting parameters (fasting glucose, HOMA-IR) in 134 SGA patients without catch-up growth (CUG) receiving GH therapy (SGA-GHT), 27 untreated SGA patients with catch-up growth (SGA-CUG), 308 iGHD patients under GH treatment, 427 children with obesity, and 356 lean controls. We adjusted for sex, age, and BMI through matching and multivariable regression.

Results

Treatment-naïve SGA-GHT patients were more insulin-resistant than iGHD patients (higher insulin AUC [P = .002] and HOMA-IR [P < .001], lower Matsuda index [P < .001]) with levels approaching those of the obesity cohort. Under GH therapy, HbA1c was higher in SGA-GHT and iGHD patients (5.26% ± 0.35 vs 5.25% ± 0.25) than in lean controls (5.09% ± 0.27). Insulin resistance in SGA-GHT patients approached levels seen in obesity. Prediabetes prevalence was highest in SGA-GHT children (11.11%) compared to those with iGHD (1.59%) or obesity (3.13%). After stopping GH therapy, SGA-GHT patients retained elevated markers of prediabetes (4.65%) and insulin resistance compared to controls and iGHD patients, similar to children with obesity (6.38%). No overt type 2 diabetes was observed.

Conclusion

SGA patients have an impaired glucose-insulin metabolism similar to that of children with obesity, which worsens under GH therapy. Close metabolic monitoring of GH-treated SGA patients is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, Small for Gestational AgeHuman Growth HormoneInsulin ResistanceInsulinPediatric ObesityDwarfism, PituitaryHumansFemaleMaleChildInfant, NewbornBlood GlucoseAdolescentGlucose Tolerance TestChild, PreschoolCase-Control Studies

Stichwörter der Autor:innen

diabetesgrowth hormone deficiencygrowth hormone therapyinsulin resistanceobesitysmall for gestational age

Substanzen

Human Growth HormoneInsulinBlood Glucose

Autor:innen und Institutionen

  • Center for Pediatric Research, Medical Faculty, University of Leipzig, University Hospital for Children & Adolescents, 04103 Leipzig, Germany.
  • Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany.
  • German Center for Child and Adolescent Health (DZKG), Partner Site Leipzig/Dresden, 04103 Leipzig, Germany.
  • Leipzig Center of Metabolism (LeiCeM), Medical Faculty, University of Leipzig, 04103 Leipzig, Germany.
  • LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, 04103 Leipzig, Germany.
  • Leipzig Reproductive Health Research Center (LE-REP), Leipzig University, 04103 Leipzig, Germany.

ORCID-Profile: Robert Stein, Ruth Gausche, Christoph Beger, Mandy Vogel, Wieland Kiess, Antje Körner

Förderung

  • German Research Foundation
  • Federal Ministry of Research, Technology and Space
  • German Center for Child and Adolescent Health
  • Hexal
  • NovoNordisk
  • Biomarin
  • German Diabetes Association
  • University Leipzig

Zitieren

APA

Prengemann, L., Stein, R., Gausche, R., Beger, C., Vogel, M., Wenzel, E., Stoltze, A., Kiess, W., Pfäffle, R., & Körner, A. (2026). Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf672

Vancouver

Prengemann L, Stein R, Gausche R, Beger C, Vogel M, Wenzel E, et al. Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf672

BibTeX
@article{Prengemann2026,
  author = {Prengemann, Lea and Stein, Robert and Gausche, Ruth and Beger, Christoph and Vogel, Mandy and Wenzel, Eric and Stoltze, Anette and Kiess, Wieland and Pfäffle, Roland and Körner, Antje},
  title = {Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf672}
}
Kostenlos starten →